The Genomic Landscape of Pediatric Acute Lymphoblastic Leukemia and Precision Medicine Opportunities

Seminars in Cancer Biology
Thai Hoa Tran, Stephen P Hunger

Abstract

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and constitutes approximately 25% of cancer diagnoses among children under the age of 15 (Howlader et al., 2013) [1]. Overall, about half of ALL cases occur in children and adolescents and it is the most common acute leukemia until the early 20 s, after which acute myeloid leukemia predominates. ALL is the most successful treatment paradigm in pediatric cancer medicine as illustrated by the significant survival rate improvement from ∼10% in the 1960s to >90% today (Hunger et al., 2015) [2]. This remarkable success stems from the progressive improvement in the efficacy of risk-adapted multiagent chemotherapy regimens with effective central nervous system (CNS) prophylaxis via well-designed randomized clinical trials conducted by international collaborative consortia, enhanced supportive care measures to decrease treatment-related mortality, in-depth understanding of the genetic basis of ALL, and refinement in treatment response assessment through serial minimal residual disease (MRD) monitoring (Pui et al., 2015) [3]. These advances collectively contribute to a decline in mortality rate of 23.5% for children diagnosed with ALL in the US from 2000 to 2010 (Smi...Continue Reading

References

Mar 6, 2002·Blood·Michael N DworzakUNKNOWN Austrian Berlin-Frankfurt-Münster Study Group
Oct 24, 2006·British Journal of Haematology·James A Whitlock
Jul 5, 2008·Cancer Cell·Akihiko Yokoyama, Michael L Cleary
Jan 9, 2009·The New England Journal of Medicine·Charles G MullighanUNKNOWN Children's Oncology Group
Aug 18, 2009·Nature Genetics·Lisa R TreviñoMary V Relling
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirk R SchultzBruce Camitta
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm A SmithGregory H Reaman
May 11, 2010·Nature Genetics·Amy L SherborneRichard S Houlston
Sep 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maurizio AricòMaria Grazia Valsecchi
Mar 11, 2011·Nature·Charles G MullighanJames R Downing
Jul 12, 2011·Cancer Cell·Kathrin M BerntScott A Armstrong
Nov 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javier G BlancoSmita Bhatia
Jan 13, 2012·Nature·Jinghui ZhangCharles G Mullighan
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heng XuJun J Yang
Jan 22, 2013·Nature Genetics·Linda HolmfeldtCharles G Mullighan
Feb 5, 2013·Nature Genetics·Julia A MeyerWilliam L Carroll
Mar 13, 2013·Expert Review of Anticancer Therapy·Denise NiewerthGertjan Kaspers
Jun 27, 2013·Blood·Scott R DaigleRoy M Pollock
Sep 10, 2013·Journal of the National Cancer Institute·Virginia Perez-AndreuJun J Yang
Dec 10, 2013·Hematology·Patrick Brown
May 24, 2014·Cancer·Malcolm A SmithNita L Seibel

❮ Previous
Next ❯

Citations

Apr 6, 2021·Frontiers in Oncology·Liwei Lv, Yuanbo Liu
May 1, 2021·International Journal of Molecular Sciences·Erica DanderGiovanni Cazzaniga
May 21, 2021·Expert Opinion on Pharmacotherapy·Magalie TardifThai Hoa Tran
Aug 12, 2021·NPJ Precision Oncology·Charlotte E J DownesDeborah L White

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Related Papers

Journal of Oncology
Aurelio Lorico, Germana Rappa
Critical Reviews in Biochemistry and Molecular Biology
Diletta DolfiniRoberto Mantovani
© 2021 Meta ULC. All rights reserved